1. Vague
    Laurence Renshaw Laurence Renshaw Malaysia says:
    May 13, 2022 at 7:57 PM

    I see two major issues:
    (1) For the 'convalescent sera', it is essential to know which variant(s) caused the infection, as that strongly affects which variants there will be immunity to.
    (2/ Differentiating double-jabbed and boosted individuals implies (incorrectly, based on the data I've seen) that a third dose is qualitatively different from a second dose. The correct way to differentiate is by the time elapsed since the _last_ dose. Whether an individual had two or three or four doses _can_ be a proxy for time since last dose, if that's the only information you have, but it isn't a very reliable one.
    Both of those issues, but especially the first, reduce the value of the results and make it difficult to draw conclusions.

    Reply
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback